Educational clinical resource

FETO for congenital diaphragmatic hernia: who may benefit?

FETO is a fetoscopic balloon procedure considered for selected severe congenital diaphragmatic hernia after detailed severity and eligibility assessment.

Medical leadDr. Ali Al-IbrahimContent updated
Conceptual visual atlas supporting this FETO for congenital diaphragmatic hernia: who may benefit? fetal surgery guide
  1. 01Fetoscopy
  2. 02TTTS laser
  3. 03FETO
  4. 04Multidisciplinary care
Conceptual fetal surgery atlasGeneral educational artwork—not an active procedure or operative instruction.
Visual guide map

How to navigate FETO for congenital diaphragmatic hernia: who may benefit?

An educational path from the first question to the next step. It does not replace individual assessment.

  1. 01Recognise the finding

    Name the maternal, fetal, placental, or pregnancy concern precisely.

  2. 02Confirm what it means

    Check gestation, diagnostic criteria, severity, and possible alternatives.

  3. 03Stratify risk

    Identify what changes maternal safety, fetal wellbeing, timing, or prognosis.

  4. 04Plan surveillance

    Match monitoring intensity to the condition and how quickly it can change.

  5. 05Escalate when needed

    Refer, admit, treat, or plan birth when thresholds are reached.

Congenital diaphragmatic hernia allows abdominal organs to enter the fetal chest and can restrict lung development. Prognosis varies widely. FETO—fetoscopic endoluminal tracheal occlusion—places a detachable balloon in the fetal trachea for a defined period to retain lung fluid and stimulate lung growth.

Severity assessment comes first

Evaluation usually includes detailed anatomy, side of the defect, observed-to-expected lung-to-head ratio, liver position, gestational age, fetal echocardiography, genetic testing, and review for additional abnormalities. Measurements must be obtained and interpreted by teams familiar with CDH because technique and reference standards affect classification.

Evidence is severity-specific

Randomised evidence in isolated severe left-sided CDH found improved survival to hospital discharge with FETO, accompanied by increased risks of preterm prelabour rupture of membranes and preterm birth. A separate trial in moderate left-sided disease did not show a significant improvement in its primary survival outcomes. These findings are why “CDH” alone is not an indication for FETO.

Balloon removal is part of the treatment

FETO requires a plan for balloon removal, usually by a later fetoscopic procedure or another established retrieval pathway. Families must know what to do if labour, membrane rupture, bleeding, or maternal illness occurs while the balloon is in place. Emergency access to a team capable of securing the fetal or neonatal airway is essential.

The neonatal pathway remains critical

FETO does not repair the diaphragm. After birth, the baby may require advanced ventilation, pulmonary-hypertension management, intensive care, and postnatal surgical repair. Counselling should cover survival, respiratory morbidity, feeding, neurodevelopment, recurrence, and long-term multidisciplinary follow-up.

FETO is available now in Abu Dhabi, subject to strict case-specific eligibility, governance, and informed consent.

References

  1. NEJM — Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia
  2. NEJM — Randomized Trial for Moderate Left Diaphragmatic Hernia